Navigation Links
Atrium Announces a Significant Increase in Revenues and Earnings for the Third Quarter of 2007
Date:11/7/2007

s before

changes in non-cash operating working

capital items 11.2 7.8 44.3%

Consolidated Results for the 9-month periods ended September 30

(unaudited)

2007 2006 Change

Revenues 272.0 223.6 21.7%

Gross Margin (1) 91.8 66.1 38.9%

33.7% 29.6%

EBITDA (2) 46.9 34.0 37.7%

17.2% 15.2%

Net Earnings 25.0 19.6 27.4%

Net earnings per share

Basic 0.81 0.65

Diluted 0.76 0.60

Cash flow from operating activities before

changes in non-cash operating working

capital items 28.5 23.4 21.5%

Consolidated Results for the 3-month periods ended September 30

(unaudited)

2007 2006 Change

Health & Nutrition

------------------

Revenues 50.9 28.3 80.0%

EBITDA (2) 15.3 7.3 109.5%

30.0% 25.8%

Active Ingredients & Speciality Chemicals

-----------------------------------------

Revenues 50.0 45.0 11.1%

EBITDA (2) 4.0 3.7 6.7%

7.9% 8.2%

Consolidated Results for the 9-month periods ended September 30

(unaudited)


'/>"/>

SOURCE Atrium Innovations Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Atrium Innovations Announces Management Changes
2. Atrium Innovations to Hold 2007 Third Quarter Financial Results Conference Call and Webcast on November 8
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
5. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
6. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
7. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
8. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
11. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... ANN ARBOR, Mich. , Aug. 26, 2014 ... pioneering the development of breakthrough oral medicines to ... science of immune modulation, today announced the appointment ... of the company,s scientific advisory board.  Dr. Singh ... and insight to advance Lycera,s multiple ongoing research ...
(Date:8/26/2014)... , Aug. 26, 2014 Trovagene, Inc. ... Generation Dx Summit; Moving Assays to the Clinic ... and Monitoring of Cell Free Tumor DNA in ... component of its Precision Cancer Monitoring (PCM) platform ... sensitivity for the detection of tumor DNA mutations ...
(Date:8/26/2014)... Cary, NC (PRWEB) August 26, 2014 ... built-in GMP processes, implemented a new pricing structure with ... better comply with cGMP and 21 CFR Part 11 ... Good Manufacturing Practices any way we can” said Rick ... the number of available users allowed customers to have ...
(Date:8/26/2014)... Ontario (PRWEB) August 26, 2014 ... Shah as its Director of Business Development. Mr. ... Spartan RX CYP2C19 System in the ... responsible for new business opportunities and strategic initiatives ... Prior to joining Spartan, Mr. Shah was the ...
Breaking Biology Technology:Lycera Appoints Harinder Singh, Ph.D., as Chair of Scientific Advisory Board 2Lycera Appoints Harinder Singh, Ph.D., as Chair of Scientific Advisory Board 3Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 2Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 3Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 4Spartan Bioscience Names Charudutt Shah as Director of Business Development 2
... , NEW YORK , July 27 ... announced the completion of a $5 million round ... Alleghany Corporation (N Y SE: Y), and other investors. ... leading position in the global online patent validation sector by ...
... /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY ) will conduct a conference call ... 2010 at 4:30 p.m. Eastern time ( 1:30 p.m. Pacific ... To participate in the ... 287-9361 (International). In addition, the call will be webcast live and can be ...
... physicists and materials scientists at the University of ... to rapidly grow centimeter-scale membranes of binary nanocrystal ... nanocrystals on a liquid surface. The study ... long-range-ordered BNSL membranes with rigorous control of nanocrystal ...
Cached Biology Technology:Article One Announces Completion of Funding from Alleghany Corporation 2Article One Announces Completion of Funding from Alleghany Corporation 3Penn collaboration leads to simpler method for building varieties of nanocrystal superlattices 2Penn collaboration leads to simpler method for building varieties of nanocrystal superlattices 3
(Date:8/25/2014)... PULLMAN, Wash.Five years ago this month, one of the ... the Washington State University campus, striking some 2,000 people. ... trove of data gathered at the time to gain ... launch the virus,s rapid spread across the university community., ... first cases came in to the university,s Health and ...
(Date:8/25/2014)... Researchers at the University of California, San Diego School of ... certain glioblastomas the primary form of a deadly brain ... not in the DNA sequence of the tumor, but in ... a priority report in the journal Oncotarget . ... by sequencing the DNA of the cancer cell," said Clark ...
(Date:8/25/2014)... family of proteins that promotes virus entry into cells ... HIV and other viruses, University of Missouri researchers have ... new insights into our understanding of not only HIV ... said Shan-Lu Liu, M.D., Ph.D., associate professor in the ... Immunology. , The study was recently published in the ...
Breaking Biology News(10 mins):WSU flu outbreak provides rare study material 2WSU flu outbreak provides rare study material 3Finding keys to glioblastoma therapeutic resistance 2MU researchers discover protein's ability to inhibit HIV release 2MU researchers discover protein's ability to inhibit HIV release 3
... shines a blue light on yeast and mammalian cells in her ... The effect is the result of a light-activated switch from a ... use this novel "on-off switch" to control cell growth or death, ... cells, said Tucker, an assistant research professor in the biology department ...
... The ocean surface is 30 percent more acidic today than it ... 50 years - a rising trend that could both harm coral ... the ocean food web, scientists warn. Despite the seriousness of ... deploy a complete suite of available tools to monitor rising acidification ...
... have found new evidence linking "Snowball Earth" glacial events to ... the National Science Foundation (NSF). Study results appear in ... The controversial Snowball Earth hypothesis posits that, on several occasions, ... thick sheet of ice lasting for millions of years. ...
Cached Biology News:Researchers could use plant's light switch to control cells 2Speed installation of system to monitor vital signs of global ocean, scientists urge 2Speed installation of system to monitor vital signs of global ocean, scientists urge 3Speed installation of system to monitor vital signs of global ocean, scientists urge 4Speed installation of system to monitor vital signs of global ocean, scientists urge 5Speed installation of system to monitor vital signs of global ocean, scientists urge 6Speed installation of system to monitor vital signs of global ocean, scientists urge 7Speed installation of system to monitor vital signs of global ocean, scientists urge 8Animal evolution springs from 'Snowball Earth' 2
...
Phospho-Btk (Tyr223) Antibody...
...
... to Ki67 - Proliferation Marker, prediluted ... related nuclear protein, expressed by proliferating cells ... cycle (G1, S, G2 and M phase). ... Ki67 antibodies are useful in establishing the ...
Biology Products: